Jane Huang - 17 Nov 2021 Form 4 Insider Report for BeiGene, Ltd. (ONC)

Role: CMO, Hematology
Signature: /s/ Qing Nian, as Attorney-in-Fact
Issuer symbol: ONC
Transactions as of: 17 Nov 2021
Net transactions value: -$392,063
Form type: 4
Filing time: 19 Nov 2021, 17:18:42 UTC
Previous filing: 21 Oct 2021
Next filing: 02 Dec 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BGNE	American Depositary Shares	Options Exercise	$179,940	+1,500		$119.96	1,500	17 Nov 2021	Direct	F1
transaction	BGNE	American Depositary Shares	Sale	$75,231	-200	-13%	$376.16	1,300	17 Nov 2021	Direct	F1, F2, F3
transaction	BGNE	American Depositary Shares	Sale	$113,142	-300	-23%	$377.14	1,000	17 Nov 2021	Direct	F1, F2, F4
transaction	BGNE	American Depositary Shares	Sale	$37,792	-100	-10%	$377.92	900	17 Nov 2021	Direct	F1, F2
transaction	BGNE	American Depositary Shares	Sale	$37,988	-100	-11%	$379.88	800	17 Nov 2021	Direct	F1, F2, F5
transaction	BGNE	American Depositary Shares	Sale	$76,282	-200	-25%	$381.41	600	17 Nov 2021	Direct	F1, F2
transaction	BGNE	American Depositary Shares	Sale	$38,242	-100	-17%	$382.42	500	17 Nov 2021	Direct	F1, F2
transaction	BGNE	American Depositary Shares	Sale	$38,416	-100	-20%	$384.16	400	17 Nov 2021	Direct	F1, F2
transaction	BGNE	American Depositary Shares	Sale	$38,528	-100	-25%	$385.28	300	17 Nov 2021	Direct	F1, F2
transaction	BGNE	American Depositary Shares	Sale	$116,382	-300	-100%	$387.94	0	17 Nov 2021	Direct	F1, F2, F6
holding	BGNE	Ordinary Shares						145,235	17 Nov 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BGNE	Share Option (Right to Buy)	Options Exercise	$0	-19,500	-7.8%	$0.000000	230,776	17 Nov 2021	Ordinary Shares	19,500	$9.23	Direct	F7, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each American Depositary Share represents 13 Ordinary Shares.
F2	The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020.
F3	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $375.76 to $376.55, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F4	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $376.89 to $377.37, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F5	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $379.61 to $380.44, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F6	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $387.82 to $388.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
F7	The number of securities underlying the option and the exercise price therefor are represented in ordinary shares.
F8	These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control.